WEST CHESTER, Ohio--(BUSINESS WIRE)--Apr. 8, 2013--
AtriCure, Inc. (Nasdaq:ATRC), a medical device company and a leader in
the development of technologies and solutions for the treatment of
atrial fibrillation, or AF, and systems for the exclusion of the left
atrial appendage, will release its financial results for the first
quarter of 2013 on Thursday, May 2, 2013.
AtriCure will host a conference call at 4:30 p.m. Eastern Time on
Thursday, May 2, 2013 to discuss its first quarter 2013 financial
results. A live webcast of the conference call will be available online
from the investor relations page of AtriCure’s corporate website at www.atricure.com.
Pre-registration is available and recommended for this call at the
You may also access this call through an operator by calling (888)
680-0892 for domestic callers and (617) 213-4858 for international
callers at least 15 minutes prior to the call start time using
reservation code 31020101.
The webcast will be available on AtriCure’s website and a telephonic
replay of the call will also be available through June 2, 2013. The
replay dial-in numbers are (888) 286-8010 for domestic callers and (617)
801-6888 for international callers. The reservation code is 45139601.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company providing innovative Atrial
Fibrillation (Afib) solutions designed to produce superior outcomes that
reduce the economic and social burden of Atrial Fibrillation. AtriCure’s
Synergy Ablation System is the first and only device approved for the
treatment of Persistent and Longstanding Persistent forms of Afib in
patients undergoing certain open concomitant procedures. AtriCure’s
AtriClip Left Atrial Appendage (LAA) exclusion device is the most widely
implanted device for LAA management worldwide. The company believes
cardiothoracic surgeons are adopting its ablation and LAA management
devices for the treatment of Afib and reduction of Afib related
complications such as stroke. Afib affects more than 5.5 million people
Source: AtriCure, Inc.
Vice President and Chief Financial Officer
Lynn Pieper, 415-202-5678